MMP2 and hepatocellular carcinoma: Suh et al. determined the levels of urinary MMP-2 and MMP-9 in HCC patients receiving radiotherapy and found that the levels of MMP-2 before radiotherapy were significantly correlated with recurrence and short progression-free survival (PFS) (Fig. 5B).